KALA – kala pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Form 10-Q KALA BIO, Inc. For: Sep 30
Form 8-K KALA BIO, Inc. For: Nov 12
Form 8-K KALA BIO, Inc. For: Sep 23
Form 424B5 KALA BIO, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.